KOSDAQ · Consumer Defensive · ₩402B
6,290원+11.72%
As of Nov 6 close
What's this stock's score right now?
See its score for free — each market is graded on its own factors.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.9% · as of 26.11.06
Among 37 신약 개발 peers
median 22.4x
median 3.0x
median -35.2%
Quarterly Revenue Growth
“신약 개발은 한 걸음 나갔고 본업 회복이 관건이에요.”
In the company's words · 2026 2분기 filing